Sustained reduction in urinary calcium during long-term treatment with slow release neutral potassium phosphate in absorptive hypercalciuria

Journal of Urology

Volumn 159, Issue 5, 1998, Pages 1451-1456

  Heller, Howard J ^a,b   Reza Albarrán, Alfredo A ^a,c   Breslau, Neil A ^a,d   Pak, Charles Y C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone density; Calcium; Delayed action preparations; Phosphates; Urinary calculi

Indexed keywords

POTASSIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG; UROPHOS K;

ADULT; AGED; ARTICLE; BONE DENSITY; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCALCIURIA; INTESTINE ABSORPTION; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0032459366     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199805000-00006     Document Type: Article

References (21)

1. Pak, C. Y. C.: Etiology and treatment of urolithiasis. Amer. J. Kidney Dis., 6: 624, 1991.
2. Weisinger, J. R., Alonzo, E., Bellorín-Font, E., Blasini, A. M., Rodriguez, M. A., Paz-Martínez, V. and Martinis, R.: Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int., 49: 244, 1996.
3. Pietschmann, F., Breslau, N. A. and Pak, C. Y. C.: Reduced vertebral bone density in hypercalciuric nephrolithiasis. J. Bone Min. Res., 7: 1383, 1992.
4. Breslau, N. A., Preminger, G. M., Adams, B. V., Otey, J. and Pak, C. Y. C.: Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J. Clin. Endocr. Metab., 75: 1446, 1992.
5. Shen, F. H., Baylink, D. J., Nielsen, R. L., Sherrard, D. J., Ivey, J. L. and Haussler, M. R.: Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J. Lab. Clin. Med., 90: 955, 1977.
6. Borghi, L., Meschi, T., Guerra, A. and Novarini, A.: Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J. Cardiovasc. Pharmacol., suppl, 22: S78, 1993.
7. Ettinger, B., Citron, J. T., Livermore, B. and Dolman, L. I.: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J. Urol., 139: 679, 1988.
8. Preminger, G. M. and Pak, C. Y. C.: Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria. J. Urol., 137: 1104, 1987.
9. Nicar, M. J., Peterson, R. and Pak, C. Y. C.: Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J. Urol., 131: 430, 1984.
10. Pak, C. Y. C.: A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis. Invest. Urol., 19: 187, 1981.
11. Van Den Berg, C. H., Kumar, R., Wilson, D. M., Heath III, H. and Smith, L. H.: Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J. Clin. Endocr. Metab., 51: 998, 1980.
12. Yates, A. J., Oreffo, R. O. C., Mayor, K. and Mundy, G. R.: Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts. J. Bone Min. Res., 6: 473, 1991.
13. Breslau, N. A., Padalino, P., Kok, D. J., Kim, Y. G. and Pak, C. Y. C.: Physicochemical effects of a new slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria. J. Bone Min. Res., 10: 394, 1995.
14. Ettinger, B.: Recurrent nephrolithiasis: natural history and effect of phosphate therapy - a double-blind controlled study. Amer. J. Med., 61: 200, 1976.
15. Lau, K., Wolf, C., Nussbaum, P., Weiner, B., DeOreo, P., Slatopolsky, E., Agus, Z. and Goldfarb, S.: Differing effects of acid versus neutral phosphate therapy of hypercalciuria. Kidney Int., 16: 736, 1979.
16. Watanabe, Y., Kubota, T., Suzumura, E., Suzuki, T., Yonezawa, M., Ishigami, T., Ichikawa, M. and Seino, Y.: 1,25-dihydroxyvitamin D radioreceptor assay using bovine mammary gland receptor and non-high performance liquid chromatographic purification. Clin. Chim. Acta, 225: 187, 1994.
17. Kivirikko, K. L., Laitinen, O. and Prockop, D. J.: Modifications of a specific assay for hydroxyproline in urine. Anal. Biochem., 19: 249, 1967.
18. Lau, K., Goldfarb, S., Goldberg, M. and Agus, Z. S.: Effects of phosphate administration on tubular calcium transport. J. Lab. Clin. Med., 99: 317, 1982.
19. Rivkees, S. A., El-Hajj-Fuleihan, G., Brown, E. M. and Crawford, J. D.: Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J. Clin. Endocr. Metab., 75: 1514, 1992.
20. Broadus, A. E., Magee, J. S., Mallette, L. E., Horst, R. L., Lang, R., Jensen, P. S., Gertner, J. M. and Baron, R.: A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism. J. Clin. Endocr. Metab., 56: 953, 1983.
21. Rowe, J. W., Andres, R., Tobin, J. D., Norris, A. H. and Shock, N. W.: The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J. Gerontol., 31: 155, 1976.